Eli Lilly Names Levi Garraway to Oncology Post

Levi Garraway is joining Eli Lilly (NYSE: [[ticker:LLY]]) as senior vice president, global development and medical affairs, of the company’s oncology unit. Garraway is currently director of the Joint Center for Cancer Precision Medicine at the Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Boston Children’s Hospital, and the Broad Institute. He is also a professor of medicine at Dana-Farber and Harvard Medical School. Garraway will succeed Richard Gaynor, who is retiring from the Indianapolis-based company. Garraway will start his new post on Jan. 1.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan